Incannex Healthcare Inc.

US$2.24As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IXHLHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (73.94%)
Div yield —
ROE (47.80%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.84
PE TTM —
TSR TTM (80.19%)
Mkt cap US$28.10M
ROIC (28.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.69
20.21%
181.68%
Hold 12|2|11|0|6
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.04
0.04
0.04
0.04
7.90%
12.28%
4.44%
4.19%
Revenue$M
3.346
3.534
3.619
3.824
4.30%
8.10%
11.74%
16.78%
Peers (US$28.10M)
Cap (US$)
PE
24.27M
—
Capital
TTM
5Y
10Y
Leveragex
1.227
(0.146)
(0.121)
EBIT/Intx
0.067
0.109
0.109
Own earn%
22.95
(30.97)
(26.19)
Sh yield%
33.21
53.15
53.49
Owners
Insiders/Inst%
14.55
25.40
Short interest%
3.53
SBC / revenue%
3.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
4–9
$1 testx
−0.2
Incr. ROIC%
4